BioNTech filed a lawsuit against Moderna for patent infringement
BioNTech has sued Moderna in a Delaware federal court, claiming that Moderna's mNEXSPIKE vaccine violates BioNTech and Pfizer's patent for their Comirnaty vaccine.
New study: booster vaccinations reduced severe consequences of COVID-19
A recent study published in the journal 'Vaccine' shows that booster vaccinations significantly decreased the incidence of severe COVID-19 outcomes, with similar efficacy found for Moderna and Pfizer/BioNTech boosters, though protection waned over time.
Hope Against Triple Negative Breast Cancer: Experimental Vaccine Shows Positive Results
An experimental mRNA vaccine shows promising outcomes in a small trial for triple-negative breast cancer patients.
Marburg Special Fund: What is Left from the BioNTech Millions
The city of Marburg has successfully invested a significant portion of its business tax revenues from the pandemic into a special fund, which is now helping to stabilize its budget.
Bayer sues the inventors of the first coronavirus vaccine for a patent
Bayer has filed a lawsuit against Pfizer, Biontech, and Moderna, claiming they copied a technology that Bayer's subsidiary, Monsanto, patented in the 1980s.
Patents: Bayer sues Biontech and Pfizer over COVID vaccines
Bayer is suing Pfizer, Biontech, and Moderna for potential patent violations related to their mRNA vaccines, claiming they copied technology from Bayer's subsidiary, Monsanto.
Financial Policy: The Problem at the Super Exchange
German Chancellor Friedrich Merz advocates for a European stock exchange to compete with the U.S., arguing that larger capital markets may offer better solutions for successful companies.